Complete response in 64% of patients in oncology is amazing. Even more so being that they were previously drug resistant. Too bad it was a poster and not a oral presentation. Hopefuly they can tee that up for the more formal resutls in '08.
Anyone got a perspective on this data?
- Forums
- ASX - By Stock
- CXS
- poster data from ash
poster data from ash
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CXS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online